Another split-face pilot study by Domingo in patients with erythema and telangiectasia (n = 4) demonstrated that although symptoms did not improve, HIF-1α and VEGF expression were reduced compared to vehicular control [40]. The gene discussed is HIF1A; the disease is Erythema.